학술논문
A phase I randomized, double-blind, placebo-controlled study to evaluate the safety, tolerability, and immunogenicity of a live-attenuated quadrivalent dengue vaccine in flavivirus-naïve and flavivirus-experienced healthy adults.
Document Type
Article
Author
Source
Human Vaccines & Immunotherapeutics; 2022, Vol. 18 Issue 5, p1-12, 12p
Subject
Language
ISSN
21645515